Per-and polyfluoroalkyl substances (PFAS) are synthetic compounds that are a major 25 public health concern due to widespread use, long environmental and biological half-lives, 26 detection in most human plasma samples, and links to multiple adverse health outcomes. The 27 literature suggests that some PFAS may be neurotoxic. However, there are major gaps in the 28 literature with respect to how environmentally-relevant doses during development may influence 29 the nervous system. To address this gap, we utilized a sentinel species, Northern leopard frogs 30 (Lithobates pipiens) to determine the effects of developmental exposure to environmentally 31 relevant perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) on major 32 neurotransmitter systems. Frog larvae at Gosner stage 25 were exposed to 10, 100, or 1000 ppb 33 PFOS or PFOA for 30 days before neurochemical analysis. High performance liquid 34 chromatography (HPLC) with electrochemical detection or fluorescent detection assays was used 35 to measure neurotransmitter levels, which were normalized to protein levels in each sample. 36 Dopamine (DA) decreased significantly in the brains of frogs treated with PFOA (1000 ppb) and 37 PFOS (100 and 1000 ppb). Significant increases in DA turnover also resulted from PFOA and 38 PFOS treatment. Neither PFOS, nor PFOA produced detectable alterations in serotonin (nor its 39 metabolite), norepinephrine, gamma-amino butyric acid (GABA), glutamate, or acetylcholine. 40 PFAS body burdens showed that PFOS accumulated relative to dose, while PFOA did not. These 41 data suggest that DArgic neurotransmission is selectively affected in developmentally exposed 42 amphibians and that PFAS should be evaluated for a potential role in diseases that target the DA 43 system. 44
Introduction 48
Per-and polyfluoroalkyl substances (PFAS) are compounds that have been extensively 49 used in manufacturing of surfactants, paper and packaging treatments, anti-static agents, 50 corrosion inhibitors, insecticides, shampoos, and firefighting foams (Posner, 2012; Stahl et al., 51 2011) . PFAS are of significant concern due in part to the stable carbon-fluorine bond and, 52 therefore, long half-life and potential for accumulation (Moody et al., 2003) . Perfluorooctane 53 sulfonate (PFOS) and perfluorooctanoic acid (PFOA) have been extensively investigated for 54 adverse health effects. While PFOS and PFOA have largely been phased out in favor of shorter 55 chain length PFAS, they are ubiquitously detected in the global population (Jian et al., 2018; 56 Olsen et al., 2009) . 57 PFOS and PFOA both cross the blood-brain barrier, with PFOS generally accumulating 58 10-100x more in mammals than many other major PFAS (Maestri et al., 2006) . Studies in large 59 mammals suggest that PFAS accumulate in the brain and are potentially neurotoxic. In polar 60 bears, brain PFAS levels (including PFOS) were found to correlate with neurotransmitter 61 alterations (Dassuncao et al., 2019) . Further, PFAS in North Atlantic pilot whales (Globicephala 62 melas) were found to accumulate in brain, where only the liver had higher levels. Here, PFAS 63 were strongly correlated with the high phospholipid content in the brain (Dassuncao et al., 2019) . 64
Laboratory studies in rodents on PFAS neurotoxicity have suggested neurobehavioral alterations. 65
For example, mice exposed to various PFAS on post-natal day 10 showed that exposure 66 increased spontaneous activity and increased proteins important for making synapses (Johansson 67 et al., 2009; Lee and Viberg, 2013) . After pregnant dams were treated with PFOA, male 68 offspring had significantly shorter latency to fall on the wire-hang test when they were 5-8 weeks 69
old, suggesting a potential motor deficit (Onishchenko et al., 2011) . This implies that PFAS 70 exposure may affect brain development. Exposures to invertebrates have shown that C. elegans 71 have decreased motor function after 48 hour exposure to PFOS (Chen et al., 2014) . Finally, in 72 vitro exposures suggest that PFAS may influence neuronal differentiation, where, in PC12 cells, 73 PFOS promoted differentiation to cholinergic neurons at the expense of differentiation to 74 dopaminergic (DA)rgic neurons, whereas other tested PFAS suppressed or enhanced overall 75 differentiation (Slotkin et al., 2008) . This research suggests that developmental exposure could 76 lead to a long-term deficit in the number of DA neurons. 77
In general, there is a lack of data on PFAS neurotoxicity and potential relevance to 78 neurological diseases. Neurobehavioral alterations have been examined in a number of 79 developmental and adult studies, with some behavioral endpoints suggesting the cholinergic 80 system as a target (Johansson et al., 2008) . In vitro studies have suggested glutamatergic 81 signaling as a target (Liao et al., 2009 ). However, environmental relevance of the tested doses is 82 generally lacking and to our knowledge no studies measured neurotransmitter levels from 83 multiple systems in response to PFAS. The primary goal of this report was to determine the 84 effects of developmental PFAS exposure at doses which include those detected in environmental 85 samples in a sentinel species. The long-term goal is to prompt specific research into how 86 exposure to PFAS during development may affect specific neurotransmitter systems and 87 influence neurological disease. 88 89 2. Methods 90 2.1 Animals, nominal exposure, and measured water and sediment PFAS levels. 91
All animal studies were approved by Purdue Animal Care and Use Committee standards. 92
The Northern leopard frog (Lithobates pipiens) was chosen as a relevant sentinel species 93 (Hoover et al., 2017) . Eggs were collected and reared to Gosner stage 25 in outdoor tanks prior 94 to the start of the experiment. Treatment tanks were prepared with 75 L of aged well water 95 (containing algae and zooplankton) and 10 kg of sediment spiked with PFOS or PFOA to 96 achieve nominal sediment concentrations of 0, 10, 100, or 1000 ppb. We chose to spike 97 sediments, instead of simple addition of chemicals to the water to represent a more ecologically 98 relevant exposure scenario. Tadpoles unintentionally consume sediment while grazing for algae 99 and detritus. Thus, spiking sediments provided more realism in incorporating all pertinent routes 100 of exposure amphibian larvae would likely experience in the environment. The doses were 101 selected to include concentrations detected at contaminated sites (Moody et al., 2003) . Measured 102 water and sediment concentrations, along with body burdens were determined by tandem mass 103 spectrometry from representative samples as previously reported (Hoover et al., 2017) . Exposure 104 lasted 30 days and tadpoles were sacrificed immediately using tricaine . For this short 105 initial report on neurotoxicity, 6-14 frogs/treatment (PFOA or PFOS at 0 to1000 ppb) were 106 randomly selected from 32 treatment tanks (~20 tadpoles housed/tank) for detailed 107 neurotransmitter analysis (81 total samples analyzed for each neurotransmitter), where the 108 majority of the animals were devoted to a long-term, non-neuronal study on systemic 109 ecotoxicity. Brains were removed, frozen in liquid nitrogen, and stored at -80 o C until processed. 110
Neurotransmitter Quantification 111
Six neurotransmitter systems were assessed. The majority of neurotransmitters were 112 analyzed by high performance liquid chromatography (HPLC) with electrochemical detection as 113 we have previously reported (Agim & Cannon, 2018; Cannon et al., 2009; Horowitz et al., 2011; 114 Wirbisky, Weber, Lee, Cannon, & Freeman, 2014; Wirbisky et al., 2015) . Neurotransmitter 115 levels in the samples were quantified by measuring the area under the curve and comparing it to 116 a standard curve. Neurotransmitter levels were then normalized to protein levels in the sample 117 (ng neurotransmitter/mg protein). DA turnover was calculated as [(DOPAC + HVA)/DA where 118 DOPAC and HVA refer to DA metabolites 4-dihydroxyphenylacetic acid and homovanillic acid, 119 respectively] (Agim and Cannon, 2018). 120 Acetylcholine (ACh) was quantified using the Invitrogen Molecular Probes Amplex 121 ACh/Acetylcholinesterase Assay Kit (A12217). Briefly, samples were diluted 1:1 in the reaction 122 buffer. Samples and standards were incubated in 200 µM amplex red, 1 U/mL horseradish 123 peroxidase, 0.1 U/mL choline oxidase and 0.5 U/mL acetylcholinesterase 1:1 reaction buffer. 124
Concentrations were determined with fluorescence spectroscopy (530 nm excitation and 590 nm 125 emission). Acetylcholine levels were normalized to protein levels in the sample (ng 126 neurotransmitter/mg protein). 127
Statistical Analysis 128
Differences in bioaccumulation of PFAS between treatments were tested using linear 129 regression on log 10 -transformed PFAS body burdens and comparisons of estimated marginal 130 means post-hoc analysis. Neurotransmitters were analyzed by one-way ANOVA with Sidak's 131 post-hoc test to compare all treatment groups within an exposure (PFOA or PFOS) and to 132 controls. Whole brain analyses of lower order species (i.e., zebrafish) produce considerably more 133 variable neurochemistry data than micro-dissected brain analysis in rodents (Dukes et al., 2016; 134 Lee et al., 2015) . Thus, outlier analysis was conducted. Statistical analyses were conducted both 135 before and after outlier analysis. Importantly, outlier analyses for raw neurotransmitter data had 136 no effect on statistical significance, where no new significant comparisons were revealed, nor 137 were any significant comparisons eliminated after outlier analysis. Outliers were identified using 138 stringent ROUT analysis (Q = 0.1%) (Motulsky and Brown, 2006) . Outlier analyses resulted in 139 no more than 3 samples/group being excluded, with the following total exclusions/endpoint: DA 140 (0/81 data points omitted), DOPAC (7/81 data points omitted), HVA (0/81 data points omitted), 141 5-HT (0/81 data points omitted), 5-HIAA (0/81 data points omitted), NE (1/81 data points 142 omitted), DA turnover (9/81), 5-HT turnover (1/81 data points omitted), glutamate (0/81 data 143 points omitted), GABA (11/81 data points omitted), and acetylcholine (0/81 data points omitted). 144
All data were expressed as mean ± standard error of the mean (SEM) and p < 0.05 used to 145 identify significant differences. 146
Results 147

Water, sediment, and body burden levels 148
Quantified PFAS exposure and body burden levels are shown in Table 1 and Figure 1 . 149 Quantification of catecholamine neurotransmitters showed a significant decrease in DA 155 in frogs treated with 1000 ppb PFOA and 100 or 1000 ppb PFOS, (3.61 ± 0.61 ng/mg protein, 156
1.62 ± 0.18 ng/mg protein, 2.41 ± 0.15 ng/mg protein, 2.09 ± 0.24 ng/mg protein for the control, 157 1000 ppb PFOA, 100 ppb PFOS, and 1000 ppb PFOS, respectively) (Figure 2A) , but no 158 significant changes in the DA metabolites DOPAC or HVA (Figure 2B, C) . DA decreases, 159 relative to metabolite levels led to a significant increase in DA turnover [(DOPAC + HVA)/DA] 160 for both 1000 ppb PFOS and PFOA (0.332 ± 0.051, 1.22 ± 0.20, 0.693 ± 0.085, 1.02 ± 0.10 for the control, 1000 ppb PFOA, 100 ppb PFOS, and 1000 ppb PFOS, respectively) ( Figure 2D) . 162
Neither PFOS nor PFOA caused significant changes in norepinephrine (NE) levels (Figure 2E) . 163
Neither serotonin (5-HT) nor its metabolite 5-hydroxyindoleacetic acid (5-HIAA) were 164 significantly affected by treatment with either PFAS, leading to no changes in 5-HT metabolism 165 (Figure 2F -H) . 166
The amino acid neurotransmitters glutamate and gamma-aminobutyric acid (GABA) 167
were measured and no significant differences were found in treatment groups versus the control 168 for either glutamate or GABA (Figure 3A, B) . In addition, there was no significant change in 169
ACh levels in any treatment group compared to the control (Figure 3C) . 170 171
Discussion 172
There are major gaps in the literature related to PFAS neurotoxicity. Here, we have 173 shown that developmental exposure within the concentration range documented at contaminated 174 sites produce selective total brain DA depletion in an amphibian sentinel species. Further, in 175 general, we observed that PFAS exposure increased DA turnover, which is typically a 176 compensatory mechanism in response to DArgic neurotoxicity and DA depletion; and an 177 additional metric of damage to DArgic function (Sossi et al., 2002) . This short report is expected 178 to prompt research on the neurochemical and neuropathological effects of PFAS on the brain. 179
Further, our findings suggest that the potential role of PFAS in neurological diseases affecting 180 DArgic neurotransmission should be examined. 181 DA depletion in the frog brain could have several implications, especially given that there 182 are some significant advantages of specific frog species as a model. Leopard frogs are unique in 183 that they have neuromelanin-containing DArgic neurons in the ventral motor neurons which could be related to the DArgic neurons in the nigrostriatal DA system that are affected in 185
Parkinson's disease (PD). Importantly, these pigmented neurons have been shown to bind PD-186 relevant toxicants, where high-neuromelanin expressing species exhibit heightened sensitivity 187 with respect to low-neuromelanin expressing species (Karlsson et al., 2009; Lindquist et al., 188 1988; Sokolowski et al., 1990; Spencer et al., 2004) . Taken together, the literature suggests 189 that, with respect to neuromelanin expression and toxicant binding to neuromelanin, certain 190 amphibian species are more representative of human DArgic neurons than low-expressing rodent 191 models. Thus, the potential relevance of DA depletion in PFAS-treated amphibians to PD should 192 be further examined. An additional common DArgic pathway in mammals is the reward system 193 with DArgic neurons extending from the ventral tegmental area to the ventral striatum (Lammel 194 et al., 2014) . Frogs have a similar DArgic pathway for reward that contains DArgic neurons in 195 the anteroventral tegmental area, thus the DA depletion that we observed could potentially result 196 in suppression of the reward pathway (O'Connell et al., 2010) . DArgic neurons are also 197 important for the hypothalamic function and multiple neuroendocrine axes that control well-198 conserved behaviors such as metabolic rate stress, digestion, and mood (Hu et al., 2008) . Thus, 199 neuroendocrine function in response to PFAS should also be tested. 200
Another important aspect of these findings potentially relates to developmental origins of 201 adult health and disease (DOHaD). It will be important to examine whether developmental PFAS 202 exposures result in increased susceptibility to neurodegenerative diseases. PD, for example is a 203 disease of aging, where, once the nigrostriatal DA reserve is depleted (i.e., loss of DA neurons 204 reaches a symptomatic threshold), the onset of clinical symptoms appear (Tabbal et al., 2012) . 205
Testing whether a developmental PFAS exposure may lower such reserve and increase 206 susceptibility later in life is of importance. 207
Relationships between PFAS treatments and body burden show log-linear 208
bioaccumulation of PFOS, whereas PFOA did not, which is consistent with the bioaccumulative 209 properties of PFOS, especially in the brain (Maestri et al., 2006) . Differences between nominal 210 and measured sediment PFAS levels are due to redistribution of the PFAS between sediment and 211 water, and to a lesser part from a mass balance perspective, to uptake by algal communities and 212 the frogs. Mass balance checks (water, sediment, and frogs) are generally within 15% of the 213 nominal mass added to the system and calculated sediment-water partition coefficients are in the 214 range reported in the literature (Higgins and Luthy, 2006) . PFAS levels observed in control 215 animals were low and to be expected, given the ubiquitous global distribution of PFAS. We 216 hypothesize that PFAS detected in control animals could be derived from the natural water 217 source used to fill tanks, algae, zooplankton and/or leaching from the plastic. 218
There are some notable limitations in the present study. Neurochemical quantification is a 219 frequent endpoint studied for effects of compounds on the brain in rodents, but has also been 220 measured in aquatic species, both in whole zebrafish larva and brains (Cannon et al., 2009; 221 Dukes et al., 2016; Milanese et al., 2012; Wirbisky et al., 2014; Wirbisky et al., 2015) . 222
However, quantification in aquatic species is more difficult and more variable than specific 223 region neurotransmitter quantification in rodents. Clearly, our samples exhibited increased 224 variability relative to micro-dissected rodent studies. Indeed, GABA and ACh analyses exhibited 225 potential nonsignificant trends resulting from PFAS treatment, suggesting further examination. 226 Future studies will require an increased number of animals/group, along with sub-regional 227
analysis. 228
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